Low disease risk in relatives of north african lrrk2 Parkinson disease patients

Neurology. 2010 Sep 21;75(12):1118-9. doi: 10.1212/WNL.0b013e3181f39a2e.

Authors

A R Troiano¹, A Elbaz, E Lohmann, S Belarbi, M Vidailhet, A-M Bonnet, S Lesage, P Pollak, C Cazeneuve, M Borg, J Feingold, A Dürr, M Tazir, A Brice; French Parkinson Disease Genetic Study Group

Collaborators

French Parkinson Disease Genetic Study Group:
Yves Agid, Alexis Brice, Alexandra Dürr, Ebba Lohmann, Marie Vidailhet, Anne-Marie Bonnet, Michel Borg, Emmanuel Broussolle, Philippe Damier, Alain Destée, Franck Durif, Jean-Luc Houeto, Pierre Pollak, Olivier Rascol, François Tison, Christine Tranchant, Marc Verin, François Viallet

Affiliation

¹ Bâtiment de la Nouvelle Pharmacie, INSERM U975-4'eme étage, Hôpital Pitié-Salpêtrière, 47 bd de l'Hôpital, Paris, 75651 cedex 13, France.

PMID: 20855856
DOI: 10.1212/WNL.0b013e3181f39a2e

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Africa, Northern
Family
Genetic Predisposition to Disease / genetics*
Humans
Leucine-Rich Repeat Serine-Threonine Protein Kinase-2
Mutation
Parkinson Disease / genetics*
Protein Serine-Threonine Kinases / genetics*
Risk

Substances

LRRK2 protein, human
Leucine-Rich Repeat Serine-Threonine Protein Kinase-2
Protein Serine-Threonine Kinases